Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain-Barré syndrome associated with accumulation of proteolytically active lymphocytes in blood.
Intraneural inflammation, that reflects emigration of immune cells from blood to nerve tissue, is a critical event in Guillain-Barré syndrome pathogenesis. To investigate the adhesion and transmigration phases of leukodiapedesis, we determined in a series of patients with GBS: (1) circulating levels of soluble forms of adhesion molecules (sICAM-1 and sVCAM-1); (2) attachment capacities of circulating lymphocytes to rICAM-1 and rVCAM-1; (3) fibronectin-penetrating capacities of circulating lymphocytes; and (4) lymphocyte intracellular concentrations of MMP-9 at the different phases of GBS and in healthy controls. Circulating levels of sVCAM-1 and sICAM-1 were above normal values at the time of progression, markedly increased at the time of plateau (sVCAM-1: P<0.03; sICAM-1: P<0.02), and tended to normalize during recovery. The percentage of cells with attachment capacities to rVCAM-1 and to rICAM-1 decreased from progression to recovery by 30 and 31%, respectively (P<0.02). The number of circulating lymphocytes with fibronectin penetrating capacities was lower than controls at the time of progression (P<0.01), then progressively increased to reach values higher than controls at the time of late recovery (P<0.02). Cellular concentrations of MMP-9 in circulating lymphocytes paralleled their fibronectin penetrating capacities. These results suggest early emigration of lymphocytes into nerve, followed by shedding of adhesion molecules from endothelium, and late decrease of lymphocyte adhesion capacities. Plateau and recovery are associated with accumulation in the vascular compartment of still proteolytically active lymphocytes that can no longer adhere to endothelial cells. Modulation of the adhesion step of leukodiapedesis may be crucially involved in the switch from progression to plateau of GBS.
Réseau de Neuroimmunologie du Nerf Périphérique (AP/HP), INSERM E. 0011, Université Paris 12-Val-de-Marne, Paris, France. creange@univ-paris12.fr
A
A
Créange
B
B
Chazaud
T
T
Sharshar
A
A
Plonquet
F
F
Poron
M C
MC
Eliezer
J C
JC
Raphaël
R K
RK
Gherardi
D002448:Cell Adhesion / Q000276:immunology; D002465:Cell Movement / Q000276:immunology*; D005500:Follow-Up Studies; D020275:Guillain-Barre Syndrome / Q000276:immunology*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood; D008214:Lymphocytes / Q000166:cytology / Q000201:enzymology / Q000276:immunology*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D020127:Recovery of Function / Q000276:immunology*; D012995:Solubility; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood
D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; D020780:Matrix Metalloproteinase 9